Well I think you are right Belco,...AND THAT IS WHAT I WANT.
A fast spike to 70 and quick profit would be a cheap thrill,... but a pull-back here to spike the rally and then slow climb to major company status and price around 300 about 4 or 5 years out ,...... well that sounds even better.
He's never said he wants to do an ex-US deal. He's said that he is willing to consider one. There is a big difference The significance of that statement is not what you think- it actually meant that a US deal was off the table. So, if you're cheering for a deal, it was actually a negative.
The real value is in the US. It's an expensive drug and countries with poor healthcare systems can't afford it. Plus there are patent problems in the EU.
He's going alone, which means the next catalyst is either AA or a big secondary to fund the drug from here.